ANJI Trademark

Trademark Overview

On Thursday, July 22, 2021, a trademark application was filed for ANJI with the United States Patent and Trademark Office. The USPTO has given the ANJI trademark a serial number of 90843473. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 8, 2024. This trademark is owned by Anji Pharmaceuticals Inc.. The ANJI trademark is filed in the Pharmaceutical Products category with the following description:

House mark for a full line of pharmaceutical preparations for human use; pharmaceutical preparations for human use for treatment and prevention of inflammatory, oncological, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, hepatic, and nephrological diseases and conditions; pharmaceutical preparations for human use for treatment and prevention of pain; pharmaceutical preparations for human use for treatment and prevention of allergies
anji

General Information

Serial Number90843473
Word MarkANJI
Filing DateThursday, July 22, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2023

Trademark Statements

Goods and ServicesHouse mark for a full line of pharmaceutical preparations for human use; pharmaceutical preparations for human use for treatment and prevention of inflammatory, oncological, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, hepatic, and nephrological diseases and conditions; pharmaceutical preparations for human use for treatment and prevention of pain; pharmaceutical preparations for human use for treatment and prevention of allergies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 23, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAnji Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAnji Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02143

Trademark Events

Event DateEvent Description
Monday, July 26, 2021NEW APPLICATION ENTERED
Thursday, September 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 15, 2022ASSIGNED TO EXAMINER
Sunday, April 17, 2022NON-FINAL ACTION WRITTEN
Sunday, April 17, 2022NON-FINAL ACTION E-MAILED
Sunday, April 17, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 7, 2022ASSIGNED TO EXAMINER
Monday, October 17, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 17, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 17, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 20, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 1, 2022WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, November 25, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, December 8, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, December 8, 2022EXAMINERS AMENDMENT E-MAILED
Thursday, December 8, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 8, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, December 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 10, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 30, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, August 7, 2023SOU TEAS EXTENSION RECEIVED
Monday, August 7, 2023SOU EXTENSION 1 FILED
Monday, August 7, 2023SOU EXTENSION 1 GRANTED
Wednesday, August 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 8, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, April 8, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

anji human pharmaceutical preparations prevention treatment dermatological genitourinary endocrinological respiratory cardiovascular